Versant Venture Management’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.15M Sell
2025
Q1
$6.41M Hold
2024
Q4
$13.5M Hold
2024
Q3
$17.6M Hold
2024
Q2
$16.2M Buy